Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy

TOMOAKI KUROKAWA, YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA and MORIHITO OKADA
Anticancer Research August 2020, 40 (8) 4387-4394; DOI: https://doi.org/10.21873/anticanres.14442
TOMOAKI KUROKAWA
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOICHI HAMAI
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yyhamai{at}hotmail.com
MANABU EMI
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTA IBUKI
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU YOSHIKAWA
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MANATO OHSAWA
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYOSUKE HIROHATA
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MORIHITO OKADA
Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 8 4387-4394
DOI 
https://doi.org/10.21873/anticanres.14442
PMID 
32727767

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 9, 2020
  • Revision received June 18, 2020
  • Accepted June 23, 2020
  • Published online July 29, 2020.

Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. TOMOAKI KUROKAWA,
  2. YOICHI HAMAI⇑,
  3. MANABU EMI,
  4. YUTA IBUKI,
  5. TORU YOSHIKAWA,
  6. MANATO OHSAWA,
  7. RYOSUKE HIROHATA and
  8. MORIHITO OKADA
  1. Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan
  1. Correspondence to: Yoichi Hamai, Department of Surgical Oncology, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8551, Japan. Tel: +81 822575866, Fax: +81 822567109, e-mail: yyhamai{at}hotmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 8
August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy
TOMOAKI KUROKAWA, YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA, MORIHITO OKADA
Anticancer Research Aug 2020, 40 (8) 4387-4394; DOI: 10.21873/anticanres.14442

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy
TOMOAKI KUROKAWA, YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA, MORIHITO OKADA
Anticancer Research Aug 2020, 40 (8) 4387-4394; DOI: 10.21873/anticanres.14442
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Clinical Significance of Pre-treatment Circumferential Tumor Location in Patients With cStage IB-III Esophageal Squamous Cell Cancer
  • Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction
  • Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy
  • Google Scholar

More in this TOC Section

  • Preoperative Cachexia Index Predicts Overall Survival Following Curative Resection for Remnant Gastric Cancer
  • Effect of Increased Image Matrix on Lung Nodule Volumetry in Chest CT: A Phantom Study
  • Prognostic Impact of the Geriatric Nutritional Risk Index in Elderly Patients With Colorectal Cancer
Show more Clinical Studies

Keywords

  • chemoradiation
  • esophagus
  • neoadjuvant therapy
  • recurrence-free survival
  • tumor response
  • prognostic factors
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire